Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (1106)	3/29/2006 9:29:57 AM
From: quidditch	Read Replies (1) \| Respond to of 1255

nigel, you would flog me, even, with my own iron in the fire (I was going to essay a variant of the saying "hoisting myself on my own petard" but concluded that the conventional interpretation would launch a bomb into our discourse). My charity portfolio, alas, bears only a 70% or so resemblance to my real life BT portfolio by issue, and the percentages by issue are not similarly aligned. But the driver of the statement I made, and to which you graciously made reference to a fact that might belie it (I claim only derivative success, based largely on the generous offerings of the wise old files on this board), resides in the decline in my mid-cap holdings, mostly SEPR, VRTX, AMLN, ALXN, and NBIX (although I'm not complaining about that one--I'm surprised it's been holding in this level at all). Those names I did not include in my contest entries because I thought their appreciation potential and high share price made them less suitable candidates. quid